Testing effectiveness (Phase 2)UnknownNCT04385186
What this trial is testing
Inactivated Convalescent Plasma as a Therapeutic Alternative in Patients CoViD-19
Who this might be right for
Infections, Coronavirus
National Blood Center Foundation, Hemolife 60